133 related articles for article (PubMed ID: 33207023)
1. Glucocorticoid effects on bone strength in children with renal diseases.
Aoyagi J; Kanai T; Ito T; Odaka J; Saito T; Betsui H; Kurosaki M; Maru T; Yamagata T
Nephrology (Carlton); 2021 Feb; 26(2):119-125. PubMed ID: 33207023
[TBL] [Abstract][Full Text] [Related]
2. Nutritional Therapy with Vitamin K
Kuwabara A; Nagae A; Kitagawa M; Tozawa K; Kumode M; Tanaka K
J Nutr Sci Vitaminol (Tokyo); 2020; 66(3):278-284. PubMed ID: 32612091
[TBL] [Abstract][Full Text] [Related]
3. Significant inverse relationship between serum undercarboxylated osteocalcin and glycemic control in maintenance hemodialysis patients.
Okuno S; Ishimura E; Tsuboniwa N; Norimine K; Yamakawa K; Yamakawa T; Shoji S; Mori K; Nishizawa Y; Inaba M
Osteoporos Int; 2013 Feb; 24(2):605-12. PubMed ID: 22581293
[TBL] [Abstract][Full Text] [Related]
4. Changes in bone turnover markers after discontinuing long-term glucocorticoid administration in children with idiopathic nephrotic syndrome: a multicenter retrospective observational study.
Ueda Y; Okamoto T; Sato Y; Hayashi A; Takahashi T; Suzuki R; Aoyagi H; Ueno M; Kobayashi N; Uetake K; Nakanishi M; Ariga T; Manabe A
Pediatr Nephrol; 2023 Oct; 38(10):3285-3296. PubMed ID: 37052692
[TBL] [Abstract][Full Text] [Related]
5. Bone turnover in passive smoking female rat: relationships to change in bone mineral density.
Gao SG; Li KH; Xu M; Jiang W; Shen H; Luo W; Xu WS; Tian J; Lei GH
BMC Musculoskelet Disord; 2011 Jun; 12():131. PubMed ID: 21663694
[TBL] [Abstract][Full Text] [Related]
6. Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis.
Nagata Y; Inaba M; Imanishi Y; Okazaki H; Yamada S; Mori K; Shoji S; Koyama H; Okuno S
Osteoporos Int; 2015 Mar; 26(3):1053-61. PubMed ID: 25403902
[TBL] [Abstract][Full Text] [Related]
7. Tartrate-Resistant Acid Phosphatase 5b in Young Patients With Sickle Cell Disease and Trait Siblings: Relation to Vasculopathy and Bone Mineral Density.
Mokhtar GM; Tantawy AA; Hamed AA; Adly AA; Ismail EA; Makkeyah SM
Clin Appl Thromb Hemost; 2017 Jan; 23(1):64-71. PubMed ID: 26149452
[TBL] [Abstract][Full Text] [Related]
8. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
[TBL] [Abstract][Full Text] [Related]
9. The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis.
Hasegawa E; Ito S; Takai C; Kobayashi D; Nomura Y; Otani H; Abe A; Ishikawa H; Murasawa A; Narita I; Nakazono K
Intern Med; 2018 Aug; 57(15):2169-2178. PubMed ID: 29607978
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of bone turnover markers in rapidly destructive coxopathy.
Abe H; Sakai T; Ogawa T; Takao M; Nishii T; Nakamura N; Sugano N
J Bone Miner Metab; 2017 Jul; 35(4):412-418. PubMed ID: 27550182
[TBL] [Abstract][Full Text] [Related]
11. Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation.
Kurosawa S; Doki N; Senoo Y; Kishida Y; Nagata A; Yamada Y; Konishi T; Kaito S; Yoshifuji K; Matsuyama N; Shirane S; Uchida T; Inamoto K; Toya T; Igarashi A; Najima Y; Muto H; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Ann Hematol; 2020 Aug; 99(8):1873-1882. PubMed ID: 32451708
[TBL] [Abstract][Full Text] [Related]
12. Effects of lanthanum carbonate on bone markers and bone mineral density in incident hemodialysis patients.
Goto K; Goto S; Fujii H; Watanabe K; Kono K; Nishi S
J Bone Miner Metab; 2019 Nov; 37(6):1075-1082. PubMed ID: 31214836
[TBL] [Abstract][Full Text] [Related]
13. Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.
Nishimukai A; Higuchi T; Ozawa H; Yanai A; Miyagawa Y; Murase K; Imamura M; Takatsuka Y; Miyoshi Y
Breast Cancer; 2017 Mar; 24(2):245-253. PubMed ID: 27040403
[TBL] [Abstract][Full Text] [Related]
14. Effects of steroid treatment on bone mineral metabolism in children with glucocorticoid-sensitive nephrotic syndrome.
Koşan C; Ayar G; Orbak Z
West Indian Med J; 2012 Sep; 61(6):627-30. PubMed ID: 23441359
[TBL] [Abstract][Full Text] [Related]
15. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
Fujita T; Satomura A; Hidaka M; Ohsawa I; Endo M; Ohi H
Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.
Ishida T; Yoshida S; Kimura Y; Fujiki Y; Kotani T; Takeuchi T; Makino S; Arawaka S
Lupus; 2018 Sep; 27(10):1636-1643. PubMed ID: 29954283
[TBL] [Abstract][Full Text] [Related]
17. Bone Mineral Density and Bone Turnover Markers Under Bisphosphonate Therapy Used in the First Year After Liver Transplantation.
Nowacka-Cieciura E; Sadowska A; Pacholczyk M; Chmura A; Tronina O; Durlik M
Ann Transplant; 2016 Apr; 21():241-9. PubMed ID: 27112626
[TBL] [Abstract][Full Text] [Related]
18. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis.
Eastell R; Christiansen C; Grauer A; Kutilek S; Libanati C; McClung MR; Reid IR; Resch H; Siris E; Uebelhart D; Wang A; Weryha G; Cummings SR
J Bone Miner Res; 2011 Mar; 26(3):530-7. PubMed ID: 20839290
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
Chen CJ; Chao TY; Janckila AJ; Cheng SN; Ku CH; Chu DM
J Pediatr Endocrinol Metab; 2005 Jan; 18(1):55-62. PubMed ID: 15679069
[TBL] [Abstract][Full Text] [Related]
20. Further significant effects of eldecalcitol on bone resorption markers and bone mineral density in postmenopausal osteoporosis patients having undergone long-term bisphosphonate treatment.
Iba K; Sonoda T; Takada J; Dohke T; Yamashita T
J Bone Miner Metab; 2017 Mar; 35(2):171-176. PubMed ID: 26832388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
